These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 27556694)

  • 1. Lactoferrin selectively triggers apoptosis in highly metastatic breast cancer cells through inhibition of plasmalemmal V-H+-ATPase.
    Pereira CS; Guedes JP; Gonçalves M; Loureiro L; Castro L; Gerós H; Rodrigues LR; Côrte-Real M
    Oncotarget; 2016 Sep; 7(38):62144-62158. PubMed ID: 27556694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity.
    Sennoune SR; Bakunts K; Martínez GM; Chua-Tuan JL; Kebir Y; Attaya MN; Martínez-Zaguilán R
    Am J Physiol Cell Physiol; 2004 Jun; 286(6):C1443-52. PubMed ID: 14761893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of plasma membrane V-ATPases is critical for the invasion of MDA-MB231 breast cancer cells.
    Cotter K; Capecci J; Sennoune S; Huss M; Maier M; Martinez-Zaguilan R; Forgac M
    J Biol Chem; 2015 Feb; 290(6):3680-92. PubMed ID: 25505184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine Milk Lactoferrin Selectively Kills Highly Metastatic Prostate Cancer PC-3 and Osteosarcoma MG-63 Cells
    Guedes JP; Pereira CS; Rodrigues LR; Côrte-Real M
    Front Oncol; 2018; 8():200. PubMed ID: 29915723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactoferrin perturbs intracellular trafficking, disrupts cholesterol-rich lipid rafts and inhibits glycolysis of highly metastatic cancer cells harbouring plasmalemmal V-ATPase.
    Santos-Pereira C; Guedes JP; Ferreira D; Rodrigues LR; Côrte-Real M
    Int J Biol Macromol; 2022 Nov; 220():1589-1604. PubMed ID: 36116593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vacuolar-ATPase Inhibition Blocks Iron Metabolism to Mediate Therapeutic Effects in Breast Cancer.
    Schneider LS; von Schwarzenberg K; Lehr T; Ulrich M; Kubisch-Dohmen R; Liebl J; Trauner D; Menche D; Vollmar AM
    Cancer Res; 2015 Jul; 75(14):2863-74. PubMed ID: 26018087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curbing Breast Cancer by Altering V-ATPase Action on F-Actin, Heterochromatin, ETV7 and mTORC2 Signaling.
    Khan ZS; Hussain F
    Cell Physiol Biochem; 2024 Jun; 58(3):250-272. PubMed ID: 38865588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine lactoferrin induces cell cycle arrest and inhibits mTOR signaling in breast cancer cells.
    Zhang Y; Nicolau A; Lima CF; Rodrigues LR
    Nutr Cancer; 2014; 66(8):1371-85. PubMed ID: 25356800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The function of vacuolar ATPase (V-ATPase) a subunit isoforms in invasiveness of MCF10a and MCF10CA1a human breast cancer cells.
    Capecci J; Forgac M
    J Biol Chem; 2013 Nov; 288(45):32731-32741. PubMed ID: 24072707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer.
    Gibbons JA; Kanwar JR; Kanwar RK
    BMC Cancer; 2015 May; 15():425. PubMed ID: 25998617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of vacuolar ATPase attenuates the TRAIL-induced activation of caspase-8 and modulates the trafficking of TRAIL receptosomes.
    Horova V; Hradilova N; Jelinkova I; Koc M; Svadlenka J; Brazina J; Klima M; Slavik J; Hyrslova Vaculova A; Andera L
    FEBS J; 2013 Jul; 280(14):3436-50. PubMed ID: 23678861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vacuolar-type ATPase inhibitor archazolid increases tumor cell adhesion to endothelial cells by accumulating extracellular collagen.
    Luong B; Schwenk R; Bräutigam J; Müller R; Menche D; Bischoff I; Fürst R
    PLoS One; 2018; 13(9):e0203053. PubMed ID: 30204757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines.
    Martínez-Zaguilán R; Raghunand N; Lynch RM; Bellamy W; Martinez GM; Rojas B; Smith D; Dalton WS; Gillies RJ
    Biochem Pharmacol; 1999 May; 57(9):1037-46. PubMed ID: 10796074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumor microenvironment through inhibiting activity of V-ATPase proton pump.
    Fan S; Niu Y; Tan N; Wu Z; Wang Y; You H; Ke R; Song J; Shen Q; Wang W; Yao G; Shu H; Lin H; Yao M; Zhang Z; Gu J; Qin W
    Oncogene; 2013 Mar; 32(13):1682-90. PubMed ID: 22580606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide production by the vacuolar-type (H+)-ATPase inhibitors bafilomycin A1 and concanamycin A and its possible role in apoptosis in RAW 264.7 cells.
    Hong J; Nakano Y; Yokomakura A; Ishihara K; Kim S; Kang YS; Ohuchi K
    J Pharmacol Exp Ther; 2006 Nov; 319(2):672-81. PubMed ID: 16895977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Novel Bisbenzimidazole Derivatives as Anticancer Vacuolar (H⁺)-ATPase Inhibitors.
    Patil R; Kulshrestha A; Tikoo A; Fleetwood S; Katara G; Kolli B; Seibel W; Gilman-Sachs A; Patil SA; Beaman KD
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28926955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. V-ATPase inhibition increases cancer cell stiffness and blocks membrane related Ras signaling - a new option for HCC therapy.
    Bartel K; Winzi M; Ulrich M; Koeberle A; Menche D; Werz O; Müller R; Guck J; Vollmar AM; von Schwarzenberg K
    Oncotarget; 2017 Feb; 8(6):9476-9487. PubMed ID: 28036299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cells.
    Roy K; Patel YS; Kanwar RK; Rajkhowa R; Wang X; Kanwar JR
    Int J Nanomedicine; 2016; 11():25-44. PubMed ID: 26730188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of silkworm vacuolar-type ATPase activity by its inhibitor Bafilomycin A1 induces caspase-dependent apoptosis in an embryonic cell line of silkworm.
    Tan XY; Wang X; Liu QS; Xie XQ; Li Y; Li BQ; Li ZQ; Xia QY; Zhao P
    Arch Insect Biochem Physiol; 2018 Nov; 99(3):e21507. PubMed ID: 30246413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. V-ATPase inhibition overcomes trastuzumab resistance in breast cancer.
    von Schwarzenberg K; Lajtos T; Simon L; Müller R; Vereb G; Vollmar AM
    Mol Oncol; 2014 Feb; 8(1):9-19. PubMed ID: 24055142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.